Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market Worth to Reach USD 15.28 billion By 2027

Posted On August 16, 2021     

The Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market report evaluates the market revenue to reach USD 15.28 billion mark in 2027. The CAGR is expected to be close to 5.5% from 2021 till the end of 2027 according to the newly published report by Value Market Research. The rise in elderly population along with the increasing prevalence of obesity, cardiovascular diseases, and erectile dysfunction are major factors driving the market growth. The rise in awareness regarding urological diseases is contributing to the growth of BPH and prostate treatment market. Also, growing preference to advanced treatment such as TURP, TUIP, TUMT and other minimally invasive techniques are likely to foster the market growth in the following timespan.

Benign prostatic hyperplasia (BPH) is the medical condition typically observed in old aged men characterized by enlargement of the prostate gland resulting into squeezing of the urethra. BPH can cause problems in the urinary bladder, kidney and urinary tract. It is often treated prescribing doses of alpha-blockers, 5-alpha reductase, or combination of other drugs. For severe conditions, minimally invasive or laser therapies are also performed to treat BPH.

The market dynamics covered in the report "Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market Report By Product (Alpha Blockers, 5-Alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitors And Others), Therapy (Monodrug Therapy And Combination Therapy) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2027" gives a holistic scope of the market along with the market forecasts.
    
On the basis of product the market is segmented into Alpha blocker, 5-Alpha reductase inhibitor, Phosphodiesterase-5 inhibitor, Others. By therapy the benign prostatic hyperplasia (bph) and prostate treatment market is categorised as Drug Treatment (Alpha Blockers, 5-Alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitors, Others),Surgical Treatment (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Laser Therapy, Prostatic Stenting, UroLift Therapy, Rezûm Therapy, Other).Geographically the research study provides data on North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions. Each region is segregated into North America (North America, United State and Rest of North America), Europe (United Kingdom, France, Germany, and Rest of Europe), Asia Pacific (China, Japan, India, Rest of Asia Pacific), Latin America (Brazil, Rest of Latin America) and Middle East & Africa. This section provides the estimates of market by segment. This section provides the estimates of market by segment thus, providing valuable data to take strategic decisions.

The Report Segments Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market -
By Product

  • Alpha blocker
  • 5-Alpha reductase inhibitor
  • Phosphodiesterase-5 inhibitor
  • Others

 
By Therapy

  • Drug Treatment (Alpha Blockers, 5-Alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitors, Others)
  • Surgical Treatment (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Laser Therapy, Prostatic Stenting, UroLift Therapy, Rezûm Therapy, Other)

 
By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 
Players Profiled In the Report:
Abbott Laboratories, Allergan plc, Astellas Pharma, Inc., Eli Lilly and Company, GlaxoSmithKline plc, Boehringer Ingelheim Pharma GmbH & Co. KG, Merck & Co., Inc., Pfizer, Inc., Sanofi, and Teva Pharmaceutical Industries Limited.

Download the FREE SAMPLE of Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market Research Report

 
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.

We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.

Contact:
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Maharashtra, INDIA.
Tel: +1-888-294-1147
Email: [email protected]
Website: https://www.valuemarketresearch.com

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Clients

Testimonials